Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Net Cash Flow (2017 - 2025)

Selectis Health's Net Cash Flow history spans 14 years, with the latest figure at -$107912.0 for Q3 2025.

  • For Q3 2025, Net Cash Flow rose 95.1% year-over-year to -$107912.0; the TTM value through Sep 2025 reached -$574148.0, up 54.02%, while the annual FY2024 figure was -$888320.0, 694.01% down from the prior year.
  • Net Cash Flow for Q3 2025 was -$107912.0 at Selectis Health, up from -$693775.0 in the prior quarter.
  • Across five years, Net Cash Flow topped out at $2.0 million in Q2 2024 and bottomed at -$2.2 million in Q3 2024.
  • The 5-year median for Net Cash Flow is -$216857.0 (2023), against an average of -$143676.6.
  • The largest YoY upside for Net Cash Flow was 758.31% in 2022 against a maximum downside of 1462.34% in 2022.
  • A 5-year view of Net Cash Flow shows it stood at $1.2 million in 2021, then tumbled by 129.13% to -$343559.0 in 2022, then crashed by 123.15% to -$766656.0 in 2023, then skyrocketed by 47.02% to -$406193.0 in 2024, then surged by 73.43% to -$107912.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Net Cash Flow are -$107912.0 (Q3 2025), -$693775.0 (Q2 2025), and $633732.0 (Q1 2025).